Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse

• Rachel J. Church ,

  Roles Conceptualization, Formal analysis, Methodology, Project administration, Writing – original draft, Writing – review & editing

  * E-mail: rchurch@unc.edu

  Affiliations Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  http://orcid.org/0000-0002-1080-6046

  ⨯
• Shelli J. Schomaker,

  Roles Conceptualization, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing

  Affiliation Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• J. Scott Eaddy,

  Roles Investigation, Project administration, Resources

  Affiliation Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Germaine G. Boucher,

  Roles Formal analysis, Investigation, Visualization, Writing – review & editing

  Affiliation Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• John M. Kreeger,

  Roles Formal analysis, Investigation, Visualization, Writing – review & editing

  Affiliation Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• Jiri Aubrecht ,

  Roles Conceptualization, Resources, Supervision, Writing – original draft, Writing – review & editing

  Current address: Takeda Pharmaceuticals, Cambridge, Massachusetts, United States of America

  ¶‡ These authors are joint senior authors on this work.

  Affiliation Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• Paul B. Watkins

  Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing

  ¶‡ These authors are joint senior authors on this work.

  Affiliations Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯